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ABSTRACT 
In rats, learning and memory performance decline during normal aging, which makes 
this rodent species a suitable model to evaluate therapeutic strategies. In aging rats, 
insulin-like growth factor-I (IGF-I), is known to significantly improve spatial memory 
accuracy as compared to control counterparts. A constellation of gene expression 
changes underlie the hippocampal phenotype of aging but no studies on the effects of 
IGF-I on the hippocampal transcriptome of old rodents have been documented. Here, 
we assessed the effects of IGF-I gene therapy on spatial memory performance in old 
female rats and compared them with changes in the hippocampal transcriptome. In the 
Barnes maze test, experimental rats showed a significantly higher exploratory frequency 
of the goal hole than controls.  Hippocampal RNA-sequencing showed that 219 genes 
are differentially expressed in 28 months old rats intracerebroventricularly injected with 
an adenovector expressing rat IGF-I as compared with placebo adenovector-injected 
counterparts. From the differentially expressed genes, 81 were down and 138 
upregulated. From those genes, a list of functionally relevant genes, concerning 
hippocampal IGF-I expression, synaptic plasticity as well as neuronal function was 
identified. Our results provide an initial glimpse at the molecular mechanisms 
underlying the neuroprotective actions of IGF-I in the aging brain.  
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INTRODUCTION 
 
In humans and rats, brain aging is associated with a progressive deterioration of spatial 
learning and memory, which makes this rodent species a suitable model to evaluate 
therapeutic strategies of potential value for correcting age-related cognitive deficits. 
Some of these strategies involve the administration of neurotrophic factors, one of 
which, insulin-like growth factor-I (IGF-I), is emerging as a promising molecule that 
plays a physiologic role in neuroprotection. Intracerebroventricular (ICV) infusion of 
IGF-I in the lateral ventricles improves reference and working memory in aging rats (1). 
Also, it has been documented that IGF-I protects hippocampal neurons from the toxic 
effects of amyloid peptides (2). Furthermore, IGF-I treatment markedly reduced the 
brain burden of Aβ amyloid in transgenic mice expressing a mutant Aβ amyloid peptide 
(3).  
Gene therapy for IGF-I in the central nervous system (CNS) of senile rats has shown 
promising results. Thus, a recombinant adenoviral vector (RAd) harboring the gene for 
rat IGF-I was used to implement IGF-I gene therapy in the hypothalamus of aging 
female rats displaying tuberoinfundibular dopaminergic neurodegeneration and chronic 
hyperprolactinemia. The treatment reversed hyperprolactinemia and increased the 
number of dopaminergic neurons in the hypothalamus of the aging rats (4). The 
ependymal route is particularly suitable for RAd-mediated gene delivery as it can 
effectively increase IGF-I levels in the cerebrospinal fluid (CSF) of rats (5). Taking 
advantage of this fact, we performed ICV IGF-I gene therapy in very old female rats 
and achieved a significant amelioration of their motor performance (6). In aging rats, it 
has been recently shown that IGF-I gene therapy significantly improves spatial memory 
accuracy as compared to control counterparts. Furthermore, in the dentate gyrus (DG) of 
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the old rats submitted to IGF-I gene therapy there was a higher number of immature 
neurons than in the old controls (7). 
There is clear evidence that a constellation of gene expression changes underlie the 
hippocampal phenotype of aging. Thus, gene expression studies in aging rodents have 
documented significant changes in hippocampal genes related to cholesterol synthesis, 
inflammation, transcription factors, neurogenesis and synaptic plasticity (8-12). While 
those studies revealed that aging itself is associated with the majority of gene expression 
changes, a smaller portion of the transcriptional differences in the hippocampus are 
related to changes in learning and spatial memory performance. The above evidence 
prompted us to assess the effect of ICV IGF-I gene delivery on the hippocampal 
transcriptome in old rats compared with placebo vector-treated counterparts.  
 
MATERIALS AND METHODS 
Animals 
Twenty three 25-months old female Sprague-Dawley rats weighing 267±5 g were used. 
Rats were housed in a temperature-controlled room (22 ± 2ºC) on a 12:12 h light/dark 
cycle. Food and water were available ad libitum. We used a commercial diet whose 
percentual composition was: humidity, 12%; protein, 23%; lipids, 7%; raw fiber, 6%; 
Total minerals, 10%, Ca, between 1.0 and 1.4%; P, between, 0.5 and 0.8%; Cl, 0.3%; 
Na, 0.2%; K, 0.7%; Mg, 0.2%; S, 0.16%. All experiments with animals were performed 
in accordance to the Animal Welfare Guidelines of NIH (INIBIOLP’s Animal Welfare 
Assurance No A5647-01). The ethical acceptability of the animal protocols used in this 
study was approved by our institutional IACUC (Protocol # T09-01-2013). 
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Spatial memory assessment 
The modified Barnes maze protocol used here has been previously documented (7,13). 
It consists of an elevated (108 cm to the floor) black acrylic circular platform, 122 cm in 
diameter, containing twenty holes around the periphery. The holes are of uniform 
diameter (10 cm) and appearance, but only one hole is connected to a black escape box 
(tunnel). The escape box is 38.7 cm long x 12.1 cm wide x 14.2 cm in depth and it is 
removable. A white cylindrical starting chamber (an opaque, 25 cm in diameter and 20 
cm high, open-ended chamber) is used to place rats on the platform with a random 
orientation of their bodies. 
Four proximal visual cues are placed in the room, 50 cm away from the circular 
platform. The escape hole is numbered as hole 0 for graphical normalized representation 
purposes, the remaining holes being numbered 1 to 10 clockwise, and −1 to −9 
counterclockwise. During the whole experiment, hole 0 remained in a fixed position, 
relative to the cues in order to avoid randomization of the relative position of the escape 
box. A 90-dB white-noise generator and a white-light 500 W bulb provided the escape 
stimulus from the platform. At the beginning of the experiment, rats were habituated to 
the task. The habituation routine consists of placing the animals in the starting chamber 
and escape box during 180 s. The purpose of habituation consists of accustoming 
animals to new environments and lowers the level of anxiety. An acquisition trial (AT) 
consists of placing a rat in the starting chamber, located at the center of the platform, for 
30 s; the chamber is then raised, the aversive stimuli (bright light and high pitch noise) 
are switched on and the rat is allowed to freely explore the maze for 120 s. The purpose 
of ATs is to train the rats on finding the escape hole. A probe trial (PT) is similar to an 
AT except that the escape box has been removed, the purpose being to assess recent 
spatial memory retention. During PTs, rats explore the maze for 90 s. The behavioral 
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performances were recorded using a computer-linked video camera mounted 110 cm 
above the platform. The performance of the subjects was determined using the Kinovea 
v0.7.6 (http://www.kinovea.org) software. The behavioral parameters assessed were as 
follows. 
(a) Escape box latency: time (in s) spent by an animal since its release from the 
starting chamber until it enters the escape box (during an AT) or until the first 
exploration of the escape hole (during a PT). A shorter escape box latency time 
indicates a better learning.  
(b) Nongoal hole exploration (errors): number of explorations of holes different from 
the escape one. Each exploration of an incorrect hole is counted as an error, provided 
that the rat lowers its nose below the plane of the table surface. 
(c) Exploration frequency: the times the rat explores every hole of the maze during the 
allotted time (90 s). A higher exploration frequency of the goal hole and the holes close 
to it indicates higher spatial memory accuracy.   
 
Helper-dependent adenovectors (HD-RAd) 
HD-RAds were constructed using a kit sold by Microbix Biosystems (Ontario, Canada). 
The kit provides the shuttle plasmid pC4HSU, the helper virus H14 and the 293 Cre4 
cell line. The construction procedure followed the guidelines of the Microbix manual 
and those described by Oka and Chan (14). Briefly, an expression cassette containing 
the gene for either rat IGF-I or the red fluorescent protein DsRed, both under the control 
of the murine cytomegalovirus (mCMV) promoter, was cloned in pC4HSU, a plasmid 
that consists of the ITRs for Ad 5 virus, the packaging signal and part of the E4 
adenoviral region plus a stuffer noncoding DNA of human origin which keeps a suitable 
size (28-31 Kbp) of the viral DNA so that it is efficiently packaged into the capsids 
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during vector generation but bands at sufficient distance from helper virus H14 in CsCl 
gradients, thus minimizing the risk of contamination of the newly generated vector. The 
shuttle vector harboring the expression cassette of interest was transfected in 293 Cre4 
cells which were then infected with the helper virus Ad H14 whose packaging signal is 
flanked by lox P sites recognized by the Cre recombinase expressed by the 293 Cre4 
cells. Therefore, the helper virus provides in trans all of the viral products necessary for 
generation of the desired HD-RAd. Following iterated coinfections with the HD-RAd 
and H14 virus, a sufficiently high concentration of HD-RAd is generated whereas very 
low levels of H14 are produced due to the cleavage of the packaging signal of H14 
effected by the Cre recombinase. The new adenovectors, termed HD-RAd-IGF-I and 
HD-RAd-DsRed as appropriate, were purified by ultracentrifugation in a CsCl gradient 
and titrated for adenoviral particles. 
 
Experimental design 
We used a modified version of the protocol for the Barnes maze paradigm already 
described in our laboratory (7, 13). On experimental day -10 the animals were 
habituated as described above. The task was organized into 3 separate sessions at one 
month interval. Every session lasted 9 days and consisted of four ATs per day, done 
every fifteen minutes. On the last day of each session, fifteen minutes after the last AT a 
PT was conducted to assess spatial memory as preference for the goal hole (hole 0). On 
experimental day -10, ten rats were allotted to group “DsRed” (injected with placebo 
Adenovirus) and 12 rats were allotted to group “IGF-I” (injected with an IGF-I 
Adenovirus) (see below). On experimental day 0 rats were ICV injected with the IGF-I 
or DsRed vector as appropriate and on day 80, CSF was obtained from the great 
cerebral cistern by puncture as previously documented (6). On experimental day 80, at 
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age 28 months,  animals were euthanized by rapid decapitation and their hippocampi 
microdissected and stored at -80°C until RNA extraction (see below) (Fig 1A). 
Stereotaxic injections. DsRed and IGF-I rats were anesthetized with ketamine 
hydrochloride (40 mg/kg; ip) plus xylazine (8 mg/kg; im) and placed in a stereotaxic 
apparatus. In order to access the lateral ventricles (LV), the tip of a 26G needle fitted to 
a 10µl syringe was placed at the following coordinates relative to the bregma: -0.8 mm 
anteroposterior, 4.1 mm dorsoventral and ±1.5 mm mediolateral (15). The animals were 
injected bilaterally with 8 µl per side of a suspension containing 1.7 x10
12 
viral particles 
of the appropriate vector. 
IGF-I assay. IGF-I was extracted from CSF samples (20 µl) by acid-ethanol 
cryoprecipitation and was radioimmunoassayed using antibody UB2-495 from L. 
Underwood and J.J. Van Wyk, which is distributed by the Hormone Distribution 
Program of the National institute of Diabetes and Digestive and Kidney diseases 
(NIDDK, Bethesda), National Hormone and Pituitary Program. Recombinant human 
IGF-I (rh IGF-I, Chiron Corp., Emeryville, CA) was used as tracer and unlabeled 
ligand. Intra and inter-assay coefficients of variation were 7.2 and 12.8%, respectively. 
 
RNA extraction, library preparation, and sequencing 
The brains from four rats per group (i.e., DsRed and IGF-I groups) were rapidly 
removed after euthanasia and their right hippocampus dissected for transcriptome 
analysis. The hippocampus was stored at -80°C until RNA extraction. 
Tissues were homogenized in TRIzol Reagent (Life Technologies). The quality of the 
isolated RNA was assessed by measuring the RIN (RNA Integrity Number) using the 
Fragment Analyzer. Library preparation for RNA-Seq was performed using the truSeq 
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RNA Sample Preparation Kit (Illumina, Cat. N° RS-122-2002) starting from 500 ng of 
total RNA. Accurate quantitation of cDNA libraries was performed using the 
QuantiFluor TM dsDNA System (Promega). The size range of final cDNA libraries 
was 280-320 bp and was determined applying the DNA Chip for NGS Libraries using 
the Fragment Analyzer (Advanced Analytical). cDNA libraries were amplified and 
sequenced by using the cBot and HiSeq2000 from Illumina (SR; 50 bp; ca. 30–35 
million reads per sample).  Raw datasets have been submitted to NCBI GEO database. 
 
RNA-Seq data analysis 
Illumina HiSeq 2000 fluorescence images were transformed to BCL files with the 
Illumina BaseCaller software and samples were demultiplexed to FASTQ files with 
CASAVA (version 1.8.2). Sequencing quality was checked and approved via the 
FastQC software. Sequences were aligned to the genome reference sequence of Rattus 
norvegicus (RGSC assembly v5.0) using the STAR alignment software (16) allowing 
for 2 mismatches within 50 bases. Subsequently, resulting SAM files were converted to 
sorted BAM files, filtering of unique hits and counting was conducted with SAMtools 
(17) and HTSeq (18). 
We used the Bioconductor package edgeR for differential expression analysis of reads 
counts arising from RNAseq between hippocampal samples from IGF-I and DsRed rats. 
(19). The list of differentially expressed genes (DEG) was established from a Log Fold 
Change > 0.5 and a p adj. value <0.05.  
Functional enrichment analyses of DEG were performed using the databases for 
annotation, visualization and integrated discovery (DAVID, 
http://david.abcc.ncifcrf.gov/), Enrichr (http://amp.pharm.mssm.edu/Enrichr/), and 
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GeneMania resources (http://genemania.org/). Data integration and plots visualization 
were done with R and the MultiExperiment Viewer software (MeV v4.9) (20). 
Q RT-PCR 
Total RNA was treated with gDNA wipeout and cDNA was synthesized with the 
Qiagen QuantiTect Reverse transcription kit (#205310). qPCR was performed with the 
MESA BLUE qPCR MasterMix Plus for SYBR Assay Low ROX on a Stratagene 
Mx3000P qPCR system. The primers used are listed in Suppl Table 1.  The 2
(-∆∆CT)
 
method was employed for measuring the gene variation between DsRed and IGF-I rats.   
 
Statistics 
Behavioral data were analyzed with the GraphPad Prism 6 Software. Latency to escape 
box and errors made were analyz d by Two way ANOVA, considering AT and 
treatment factors. When ANOVA was significant, comparisons between means and 
AT1 were performed with the Sidak post hoc test. Unpaired t-test was used for IGF-I 
levels, goal hole exploration in PTs and qRT-PCR. For RNAseq data analysis, as 
described above, we used the statistical language R and the analysis packages from 
Bioconductor. 
 
RESULTS 
Effects of IGF-I gene therapy on spatial memory 
Latency and errors to escape box. The treatment did not induce significant changes in 
either latency or errors to escape box, two parameters that are a measure of learning 
ability. During the first series of AT sessions, (before treatment), both parameters fell 
significantly at comparable rates in the two groups (Two way ANOVA, Treatment 
factor p=0.19, AT factor p<0.0001, interaction p=0.34) (Sidak post-hoc test AT2 
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onwards vs AT1 p<0.0001). During sessions 2 and 3 both latency and errors to escape 
box remained low in both groups, indicating that the animals remembered the location 
of the escape hole as well as at the end of session 1 (Fig. 1B&C).  
Hole exploration frequency. As expected, hole exploration frequency showed 
overlapping bell-shaped distributions around hole 0 in the pre-treatment PT (Fig. 1D). 
Thirty-eight days after vector injection the distribution of exploration frequency 
remained comparable in both groups (Fig. 1E), but at 77 days post-treatment, 
exploration frequency of the goal hole (hole 0) in the IGF-I group was significantly 
higher than in the DsRed counterparts (unpaired t-test t=2,644, df=20, p=0.016). (Fig. 
1F). The higher exploration frequency displayed in PT3 by the IGF-I rats at the goal 
hole suggests that at this time point, the treatment increased the accuracy of spatial 
memory in the aged animals.  
Ventricular transgene expression and IGF-I levels  
Two days after ICV DsRed adenovector injection there was a strong expression of 
DsRed in the ependymal cells lining the cerebral ventricles (Fig 2A, B, C and D). 
Eighty days after vector injection (on the day of sacrifice) transgene expression in the 
ependymal cell layer was still observable (Fig 2E, F and G). On experimental day 80 
CSF levels of IGF-I were significantly higher in the IGF-I group than in the DsRed 
counterparts (unpaired t-test t=4.967, df=5, p=0.0042) (Fig 2H). The results of this 
section indicate that transgene expression of the adenovector genome in the ependymal 
cells remains active for at least 80 days after injection.  
Hippocampal genes whose expression is modified by IGF-I gene therapy in old rats 
Analysis of the hippocampal transcriptome of old rats revealed that after long-term IGF-
I gene therapy, 219 genes were significantly (P<0.05) differentially expressed, 81 down 
and 138 up (Suppl table 2). We performed quantitative RT-PCR analysis of 4 
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representative transcripts namely, Itga 8, Sypl2, Dusp1 and Nnat. The results were in 
line with the RNAseq data (Fig 3D). 
From those genes, a list of functionally relevant genes, concerning hippocampal IGF-I 
expression, synaptic plasticity as well as neuronal function was identified (Table 1). 
They were grouped as follows. 
Hippocampal genes related to IGF-I expression and transport- Expression of IGF-I 
and its binding protein IGFBP-6, in the hippocampus was significantly upregulated by 
ICV IGF-I gene therapy. In contrast, the treatment downregulated the expression of the 
gene encoding IGF binding protein IGFBP-4.  Data analysis using the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) database collections revealed that the 
IGF-I gene is functionally linked to a number of metabolic pathways and to several of 
the hippocampal genes differentially expressed by the treatment (Fig. 3).  
Genes involved in synaptic plasticity and neurogenesis- Three genes related with 
synaptic processes were up-regulated after IGF-I gene therapy. The up-regulated genes 
were Synaptophysin-like protein 2 (Sypl2), Neuronatin (Nnat) and integrin α8 subunit 
(Itga-8). Sypl2 is an integral component of synaptic esicle membrane, cellular calcium 
ion homeostasis, transporter activity and substantia nigra development (see the 
Discussion section for further details).  
Nnat mRNA is abundant in dendrites particularly in rat brain embryos.  
ITGA8 expression in brain mediates cell-cell interactions and regulates neurite 
outgrowth of sensory and motor neurons. The neurogenesis related gene DCX, that 
encodes the cytoskeletal protein doublecortin, was significantly upregulated by the 
treatment. 
Micro RNA 186 (miRNA 186) and β-site amyloid precursor cleavage- IGF-I gene 
therapy up-regulated miRNA-186 in the hippocampus of 28 months old female 
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Sprague-Dawley rats.  miR-186 is a potent negative regulator of β-site amyloid 
precursor protein-cleaving enzyme 1 (BACE1) in neuronal cells (see Discussion for 
further details and references). 
Miscelaneous genes downregulated by IGF-I gene therapy in old rats- DUSP1 and 
Nr4a1 encode for DUSPI (phosphatase) and Nr4a1 (transcription factor), two proteins 
induced when the glucocorticoid receptor is phosphorylated and activated.  
Taken together, the results of this section show that among the hippocampal genes 
whose expression was modified by the treatment there is a set of genes functionally 
relevant to a number of hippocampal activities affected by aging.  
  
DISCUSSION 
Cognitive aging leads to a progressive decline in memory function. There is a reduced 
persistence of experimentally induced, long-term potentiation (LTP) of hippocampal 
synapses, which is correlated with faster behavioral forgetting of spatial information 
(21).  Spatial memory of aged rats is also impaired as revealed by various tests of spatial 
learning and memory (13,22-24). Hippocampal neurogenesis is important for certain 
types of memory and falls significantly in aged rats (13,25). The present results confirm 
our previous findings on the restorative ability of IGF-I gene therapy on spatial memory 
accuracy (7,26).  
Gene-expression changes in the hippocampus during aging 
There is clear evidence that a constellation of gene expression changes underlie 
hippocampal phenotype aging. Thus, gene expression studies in aging rodents have 
documented significant changes in hippocampal genes related to cholesterol synthesis, 
inflammation, transcription factors, neurogenesis and synaptic plasticity. In rodents, 
aging and, to a lesser extent, deficits in memory performance have been associated with 
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changes in hippocampal gene expression (8-12). These differences consist mostly of 
gene upregulation in middle-aged mice (15-mo old) as compared with 2-mo old 
counterparts (12).  In the CA1 hippocampal region of old male rats 233 genes were 
found to be differentially expressed with aging, 60% upregulated and 40% 
downregulated (8). We have recently found that in the entire hippocampus of female 
rats, 210 transcripts are differentially expressed in old animals when compared with 
young counterparts, with 61% being downregulated and 39% upregulated (27). 
 
Hippocampal transcriptome changes induced by IGF-I gene therapy in old rats  
To our knowledge, there are no documented studies on the effects of neuroprotective 
factor treatment on the hippocampal transcriptome of aging rats. Since we have 
characterized the restorative effect of IGF-I gene therapy on cognitive performance in 
aging female rats (7), we were interested in correlating the transcriptome changes 
induced by long-term IGF-I gene therapy on the hippocampus of aging female rats with 
hippocampal function improvement. To this end, we performed RNA-seq analysis of 
the whole female rat hippocampus of old rats ICV injected with a helper dependent-
adenovector expressing rat IGF-I comparing the results with placebo vector-treated 
counterparts.  
From the 219 genes significantly differentially expressed by IGF-I gene therapy in the 
hippocampus of old rats, we could identify a short list of genes relevant to IGF-I 
expression and transport, synaptic plasticity and neurogenesis as well as neuronal 
function.  
 
Genes related to IGF-I- Since our IGF-I adenovector was delivered via ICV, the IGF-I 
gene upregulation recorded in the hippocampus must reflect the expression of the 
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endogenous rat gene, implying that transgenic IGF-I directly or indirectly stimulated 
hippocampal IGF-I production. Increased expression of IGF-I in the hippocampus is 
likely to have played a significant role in the deregulation of a number of hippocampal 
genes in the experimental old rats (Fig. 3). The IGFBP4 and IGFBP6 binding proteins 
are members of the insulin-like growth factor binding protein family. They bind and 
prolong life in blood of both insulin-like growth factors (IGFs) I and II and alter their 
interaction with cell surface receptors (28,29). 
The treatment downregulated the expression of IGFBP4 and upregulated the expression 
of IGFBP6. Consequently, hippocampal tissue levels of free IGF-I and IGF-II are likely 
to have changed as a result of the altered proportion of these two binding proteins.   
    
Genes involved in synaptic plasticity and neurogenesis- Four genes related with 
synaptic processes and neurogenesis were up-regulated after IGF-I gene therapy, 
namely Sypl2, Nnat, Itga-8 and DCX.  
Sypl2, mouse aliase Mitsugumin 29, is an integral component of synaptic vesicle 
membrane, it regulates cellular calcium ion homeostasis, transporter activity and 
substantia nigra development (30). Sypl2 is a distinctly inducible gene also in human 
astrocytes surrounding Aβ-containing senile plaques in vivo. In lesions of Alzheimer´s 
Disease (AD) brain, increased expression of Sypl2 is detected only in activated 
astrocytes. But in quiescent astrocytes in non-AD brain and in lesion-free areas of AD 
brains, the expression of this gene is controlled at a low level (31). We hypothesize that 
overexpression of Sypl2 in astrocytes could play a neuroprotective role, preventing the 
development of senile plaques.  
Nnat is a maternal imprinted gene, which encodes a membrane protein in the 
endoplasmic reticulum (32,33). mRNA levels are highest early in brain development 
Page 15 of 45
http://mc.manuscriptcentral.com/jgbs
Manuscripts submitted to Journal of Gerontology: Biological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
16 
 
and decrease postnatally (34). However, traces of neuronatin mRNA continue to be 
present even in the adult brain including the hypothalamus, hippocampus and pituitary 
gland (35-37). NNAT, shown to be enriched in isolated dendrites, provides a means for 
rapidly eliciting site-specific changes in protein levels during neuronal development and 
synaptic plasticity (35,36,38). Importantly, NNAT levels increase during neurogenesis 
(between E16–19) (35). Oyang and col. reported that NNAT is indeed dendritically 
translated in mature hippocampal neurons during homeostatic plasticity and that it likely 
regulates dendritic calcium by modulation of intracellular Ca2+ stores by antagonizing 
SERCA pump activity (37). Although high embryonic and early postnatal expression 
has suggested significant roles for NNAT during neuronal development and 
neurogenesis, its function in mature neurons has not been examined. Here, we show that 
IGF-I up-regulated NNAT in the senile hippocampus, which suggests that this peptide 
may be playing a significant modulatory role in neuronal plasticity during aging. 
Α8-integrin (ITGA8) expression in the brain mediates cell-cell interactions and 
regulates neurite outgrowth of sensory and motor neurons (39,40). Accumulating 
evidence has implicated integrin function in the CNS physiology underlying synaptic 
and behavioral plasticity. Mice deficient in α8–integrin in the forebrain are impaired 
specifically in the expression of hippocampal LTP (40). In this context, the up-
regulation of α8–integrin in the hippocampus of senile rats reported here could 
contribute to restoring LTP and consequently, improve spatial memory. 
Doublecortin is a cytoskeleton-associated protein (41) present in immature neurons. As 
such, DCX expression in the hippocampal DG indicates quantity of immature neuron 
count (neurogenesis). In a previous study, we observed that IGF-I gene therapy prompts 
an increase in DCX (+) neuron number in the DG of senile rats (7). Thus, the 
upregulation reported herein is in line with our previous findings.  
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miRNAs role in aging brain and Alzheimer disease pathology- Studies on the roles 
that microRNAs (miRNAs) play in brain aging and AD pathogenesis have only recently 
been initiated (42-45). MiRNAs are endogenous small RNA molecules that control gene 
expression post-transcriptionally, primarily through binding to complementary target 
sequences in the 3´ untranslated regions (UTRs) of mRNAs. Age is significantly 
associated with a decline in miRNA expression levels in the brains of fish (46), mice 
(45,47,48), rats (49), chimpanzees (44), rhesus macaques (42,44), and even humans 
(42,44). Moreover, low miRNA levels are likely to contribute to loss of brain 
functioning and neurodegeneration (50-52).  
In this context, our finding that IGF-I gene therapy up-regulates miR-186 in the 
hippocampus of 28 months old female Sprague-Dawley rats is likely to be relevant for 
improvement of memory function. miR-186 expression is significantly decreased in 
mouse cortices at 13 months of age, compared to 2 months of age, and it shows a trend 
to further decrease at 24 months of age. In the brain, miR-186 is broadly expressed 
across multiple brain subregions in mice (53). miR-186 is a potent negative regulator of 
β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in neuronal cells and it 
may be one of the molecular links between brain aging and the increased risk for AD 
during aging (53). Importantly, miR-186 over-expression significantly decreases Aβ 
level by suppressing BACE1 expression in cells expressing human pathogenic mutant 
amyloid precursor protein (53). In this context, our finding that IGF-I up-regulates miR-
186 levels in the hippocampus of senile rats suggests a neuroprotective role. 
 
Concluding Remarks 
The present study shows for the first time, to the best of our knowledge, that IGF-I gene 
therapy in the brain of aging rats induces significant changes in the expression of a large 
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number of hippocampal genes (219). Although we cannot determine the functional 
relevance of all of them in hippocampal function, we could identify a limited number of 
upregulated genes that play a significant role in synaptic plasticity and neurogenesis. 
Interestingly, IGF-I upregulates the expression of miRNA 186, a micro RNA whose 
production declines with age and which exerts a neuroprotective action by inhibiting the 
activity of BACE1 protease. Furthermore, the IGF-I gene and one of its binding proteins 
were also upregulated. Our results provide an initial glimpse at the molecular 
mechanisms underlying the neuroprotective actions of IGF-I in the aging brain. 
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Table 1 
Effect of IGF-I gene therapy on functionally relevant hippocampal genes of old 
rats 
 
 
The indicated references are included in the general Reference list at the end of the 
paper. The number of arrows for each gene indicates the magnitude of its deregulation 
in the old rats of the IGF-I group versus the DsRed counterparts.  
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FIGURE LEGENDS 
Figure 1. Effect of IGF-I gene therapy on the performance of old rats in the Barnes 
Maze.-  Panel A, shows a diagram illustrating the experimental design used. Learning 
ability was assessed by performing 3 sessions of 9 days each (4 AT per day) with a 30-
day interval between each session. On the last day of each session a probe trial (PT) was 
conducted.  DsRed or IGF-I adenovectors were ICV injected on Experimental Day 0 
(syringe icon).  Eut= Euthanize. Panels B and C show latency to escape hole and error 
number during the three sessions performed during the experiment. Arrows indicate 
vector injection day. Panels D, E and F show hole exploration frequency in probe trials 
1, 2 and 3. Notice the sharp increase in exploratory frequency of hole #0 (escape hole) 
in the IGF-I group at PT3. Data are represented as mean ± SEM. Comparisons between 
IGF-I vesus DsRed are made for each pair of IGFI – DsRed time points. *: P<0.05. N 
was 10 for DsRed group and 12 for IGF-I group. 
 
Figure 2.  Transgene expression and IGF-I levels in the CSF of DsRed and IGF-I 
rats. Panel A shows a brighfield image of the LV of an old rat 2 days after DsRed 
adenovector injection. Panel B shows expression (red fluorescence) of DsRed in the 
ependymal layer of the LV. Panel C represents a magnification of the yellow framed 
region shown on Panel B. Panel D shows a diagrammatic representation of the 
ependymal cell layer shown on Panel C. Panels E, F and G show DsRed fluorescence, 
DAPI staining and merge of the two colors, respectively, in the 3V at the end of the 
experiment (Exp. Day 80). Panel H shows CSF IGF-I levels on Exptl. day 80 in DsRed 
and IGF-I animals. N was 3 and 4 for the DsRed and IGF-I groups, respectively. LV, 
lateral ventricle; 3V, third ventricle; CPu, caudate Putamen. Scale bar for panel 
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B=250µm which also applies to panel A; scale bar for panel G=100 µm which also 
applies to panels C, E, and F.   
 
Figure 3. A. Heatmap representation of the 219 DEG (138 up & 81 down) genes 
between DsRed and IGF-I rats ordered according to the LogFC values. B. Functional 
enrichment of the upmodulated genes in IGF-I rats, based on Kegg-2016 gene set 
library. C. Network representation of IGF-I related genes obtained from the list of 
upmodulated genes. Red nodes indicate genes from the query gene list, whereas blue 
nodes indicates genes related to the query. D. Bar plots representing qRT-PCR of four 
representative genes induced and repressed by IGF-I gene therapy: N=4 for both groups.  
Bars represent mean ± SD. * p<0.05, **p<0.01, ***p<0.001. 
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Figure 1. Effect of IGF-I gene therapy on the performance of old rats in the Barnes Maze.-  Panel A, shows a 
diagram illustrating the experimental design used. Learning ability was assessed by performing 3 sessions of 
9 days each (4 AT per day) with a 30-day interval between each session. On the last day of each session a 
probe trial (PT) was conducted.  DsRed or IGF-I adenovectors were ICV injected on Experimental Day 0 
(syringe icon).  Eut= Euthanize. Panels B and C show latency to escape hole and error number during the 
three sessions performed during the experiment. Arrows indicate vector injection day. Panels D, E and F 
show hole exploration frequency in probe trials 1, 2 and 3. Notice the sharp increase in exploratory 
frequency of hole #0 (escape hole) in the IGF-I group at PT3. Data are represented as mean ± SEM. 
Comparisons between IGF-I vesus DsRed are made for each pair of IGFI – DsRed time points. *: P<0.05. N 
was 10 for DsRed group and 12 for IGF-I group.  
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Figure 2.  Transgene expression and IGF-I levels in the CSF of DsRed and IGF-I rats. Panel A shows a 
brighfield image of the LV of an old rat 2 days after DsRed adenovector injection. Panel B shows expression 
(red fluorescence) of DsRed in the ependymal layer of the LV. Panel C represents a magnification of the 
yellow framed region shown on Panel B. Panel D shows a diagrammatic representation of the ependymal cell 
layer shown on Panel C. Panels E, F and G show DsRed fluorescence, DAPI staining and merge of the two 
colors, respectively, in the 3V at the end of the experiment (Exp. Day 80). Panel H shows CSF IGF-I levels 
on Exptl. day 80 in DsRed and IGF-I animals. N was 3 and 4 for the DsRed and IGF-I groups, respectively. 
LV, lateral ventricle; 3V, third ventricle; CPu, caudate Putamen. Scale bar for panel B=250µm which also 
applies to panel A; scale bar for panel G=100 µm which also applies to panels C, E, and F.    
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Figure 3. A. Heatmap representation of the 219 DEG (138 up & 81 down) genes between DsRed and IGF-I 
rats ordered according to the LogFC values. B. Functional enrichment of the upmodulated genes in IGF-I 
rats, based on Kegg-2016 gene set library. C. Network representation of IGF-I related genes obtained from 
the list of upmodulated genes. Red nodes indicate genes from the query gene list, whereas blue nodes 
indicates genes related to the query. D. Bar plots representing qRT-PCR of four representative genes 
induced and repressed by IGF-I gene therapy: N=4 for both groups.  Bars represent mean ± SD. * p<0.05, 
**p<0.01, ***p<0.001.  
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Gene Forward primer
Itga8 TGATTACCCAGATTTACTTGTCGG
Sypl2 GACTGATGTCAAAGGGGCCA
Dusp1 TGATCAACGTCTCGGCCAAT
Nnat CTCTTGCTGTCCCTTGCCTAT
Bactin GGGAAATCGTGCGTGACATT
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Reverse primer Amplicon size (bp)
AGCTGGGCATCCACTGTTAC 90
AGCCAAAGAGCACAGAGATGT 134
TCACGAACTCAAAGGCCTCG 258
CTGCGTGAGACCAGGGATAAG 204
ATGGTGGTGCCGCCAGACAG 149
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edgeR Analysis Result
List of DEG between IGF1 and DsRED rats (LogFC>1.5; pvalue<0.05)
Gene_Name logFC logCPM PValue FDR Significance
Alox15 -3.544625037 2.060801424 1.78404E-05 0.017324325 Down in IGF1
Ttr -2.851922036 5.445466731 9.63022E-05 0.068906789 Down in IGF1
S100a8 -2.703027443 1.641117278 0.000263423 0.143249649 Down in IGF1
S100a9 -2.675150871 2.604995881 1.54801E-05 0.017324325 Down in IGF1
AABR07051735.1 -1.860949763 1.356074144 1.72897E-05 0.017324325 Down in IGF1
Apold1 -1.771191413 5.223560107 1.63337E-12 2.22057E-08 Down in IGF1
Alas2 -1.639376162 1.350656007 7.37866E-06 0.011145881 Down in IGF1
Spink5 -1.594578794 -0.025886869 5.72801E-05 0.045807223 Down in IGF1
Mfrp -1.5932081 1.635883717 0.003348393 0.65211732 Down in IGF1
Clic6 -1.568614911 1.423830396 0.003919178 0.701068698 Down in IGF1
Cxcl9 -1.556173259 1.255514069 0.069885506 1 Down in IGF1
Slc4a5 -1.539433839 0.946849141 0.007960898 0.852687314 Down in IGF1
Hba1 -1.374973885 6.752948896 2.95623E-06 0.005741412 Down in IGF1
AABR07054319.1 -1.331411003 6.487702149 5.30864E-05 0.045106878 Down in IGF1
Hba2 -1.309422158 5.264746182 7.29506E-06 0.011145881 Down in IGF1
Sik1 -1.233674974 2.863215367 1.07016E-09 3.63722E-06 Down in IGF1
Hbb-b1 -1.151898075 1.481864752 0.002073635 0.525052326 Down in IGF1
Ccl5 -1.146444014 0.098535456 0.03007257 1 Down in IGF1
Ifit3 -1.048794622 1.947829407 0.005839419 0.770746642 Down in IGF1
Loxl4 -0.907352347 0.733147865 0.00814876 0.854422119 Down in IGF1
Aqp1 -0.90090843 0.320749275 0.013164854 0.944967997 Down in IGF1
Klf2 -0.892603602 3.687472932 6.39918E-10 2.8999E-06 Down in IGF1
AC128800.1 -0.892365642 2.243955219 1.40286E-05 0.017324325 Down in IGF1
Ibsp -0.891670142 0.375587901 0.004908365 0.741060084 Down in IGF1
Atf3 -0.878008739 0.728349008 0.006636121 0.810426825 Down in IGF1
Hif3a -0.875898282 1.919379991 0.018077797 1 Down in IGF1
Tmem252 -0.867531069 1.587577663 0.00871796 0.878567081 Down in IGF1
C2cd4a -0.857634989 0.195161352 0.030807778 1 Down in IGF1
Lrg1 -0.84840963 2.482627098 0.025645719 1 Down in IGF1
Dusp1 -0.846454656 5.549043965 1.38277E-08 3.75976E-05 Down in IGF1
Cd3e -0.825037335 3.269563149 0.256578733 1 Down in IGF1
Nts -0.813083912 4.788617728 0.021579663 1 Down in IGF1
Angpt2 -0.802477629 1.107380965 0.041501758 1 Down in IGF1
Fmo3 -0.785456999 2.949919704 0.000663266 0.28294506 Down in IGF1
-0.763355542 1.540103178 0.038280967 1 Down in IGF1
RGD1566307 -0.761078087 1.492068638 0.151779932 1 Down in IGF1
Btg2 -0.75895809 4.60712286 2.34596E-11 1.59467E-07 Down in IGF1
Cyr61 -0.743046809 1.461317051 0.011056952 0.920218261 Down in IGF1
-0.739099361 1.525405148 0.00185802 0.502763925 Down in IGF1
Tmem207 -0.730003781 1.400930675 0.005369777 0.741060084 Down in IGF1
Serpinb1a -0.723279954 1.757542585 0.00682534 0.810426825 Down in IGF1
Ccdc37 -0.714731088 1.241198871 0.090102049 1 Down in IGF1
Tp73 -0.713877408 2.632606413 0.059418913 1 Down in IGF1
Grap2 -0.712420791 1.720281004 0.01267595 0.944967997 Down in IGF1
Pla2g3 -0.71007318 2.935655759 0.049246815 1 Down in IGF1
Napsa -0.708808721 0.066079829 0.063651604 1 Down in IGF1
-0.700103802 2.29824211 0.167569602 1 Down in IGF1
Trpm1 -0.693073958 0.923783155 0.142461402 1 Down in IGF1
-0.680552274 3.709354869 0.011526556 0.943997182 Down in IGF1
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Klf4 -0.678354385 2.974922755 0.001769512 0.501088366 Down in IGF1
Igfbp4 -0.66356559 4.592135446 0.000121215 0.082396194 Down in IGF1
Tspo -0.661856563 1.470184417 0.006128005 0.793430781 Down in IGF1
Spata18 -0.658465803 1.965104688 0.173114289 1 Down in IGF1
Lingo3 -0.653712797 4.432203214 0.001562115 0.473768859 Down in IGF1
Agbl2 -0.648497905 0.974741027 0.079647384 1 Down in IGF1
Fam84b -0.646932698 1.051909505 0.064554999 1 Down in IGF1
Fam110d -0.642343354 1.609041313 0.019754661 1 Down in IGF1
C4b -0.638914615 1.85333263 0.020140057 1 Down in IGF1
Nr4a1 -0.635575264 5.87118157 2.6537E-07 0.000601283 Down in IGF1
AABR07004112.1 -0.627239117 1.651615012 0.110022524 1 Down in IGF1
RT1-CE16 -0.619805513 4.045552928 0.063176251 1 Down in IGF1
Fos -0.614310109 3.761988541 0.000792568 0.326514057 Down in IGF1
Tmem114 -0.608994049 0.869890465 0.049787689 1 Down in IGF1
Ackr2 -0.608417181 1.741117729 0.037060207 1 Down in IGF1
Cdkn1a -0.606971958 3.55431549 0.009282299 0.894984764 Down in IGF1
-0.603176065 0.922732575 0.05272995 1 Down in IGF1
Synpo2 -0.602503735 1.877775341 0.021906462 1 Down in IGF1
Wfs1 -0.599160178 8.730176448 0.053205217 1 Down in IGF1
Yjefn3 -0.599033063 3.348197876 0.002603278 0.570831675 Down in IGF1
Epha8 -0.596428785 6.568671071 0.04968537 1 Down in IGF1
Enpp3 -0.595218689 0.279249923 0.050471895 1 Down in IGF1
P2ry2 -0.590213175 0.843695183 0.02709475 1 Down in IGF1
Lrrc74b -0.589457765 0.725313715 0.195512468 1 Down in IGF1
Acer2 -0.588152042 4.983052133 0.001130644 0.404502735 Down in IGF1
Ppp1r32 -0.583553856 1.810783199 0.282273698 1 Down in IGF1
Il21r -0.583147762 0.353602312 0.063308701 1 Down in IGF1
LOC686662 -0.583037599 0.1281437 0.060685311 1 Down in IGF1
-0.58044193 3.970696447 0.123985346 1 Down in IGF1
Lcn2 -0.578935833 1.624565178 0.082828525 1 Down in IGF1
Klk11 -0.576549352 1.230646859 0.01999798 1 Down in IGF1
Dll4 -0.569498795 1.814425846 0.004785515 0.741060084 Down in IGF1
Clca4 1.154917846 1.486819572 0.241098165 1 Up in IGF0
Cbx2 0.503300414 1.248829283 0.040513049 1 Up in IGF1
Jag1 0.506842971 2.655892949 0.030967667 1 Up in IGF1
Pzp 0.511828278 0.248301887 0.133290254 1 Up in IGF1
Fcgbp 0.512177956 2.164738293 0.123883942 1 Up in IGF1
Rgs4 0.513448798 5.497601811 0.04385449 1 Up in IGF1
AABR07016841.1 0.515817426 3.90623261 0.000227563 0.128905241 Up in IGF1
Ldb2 0.519328715 4.984802214 0.018490745 1 Up in IGF1
AC142180.1 0.5196826 0.38808575 0.083861002 1 Up in IGF1
Tgfb3 0.522408949 3.943710973 0.049262109 1 Up in IGF1
Sema3f 0.522813229 1.391828332 0.095660004 1 Up in IGF1
Pde4c 0.524345729 1.271721427 0.037740869 1 Up in IGF1
Hpcal1 0.525480804 4.709904177 0.029672137 1 Up in IGF1
Fras1 0.527580304 3.834111057 0.108833038 1 Up in IGF1
Dcx 0.53293664 5.069111987 0.010834067 0.909192252 Up in IGF1
Atp8b3 0.533018128 1.969583485 0.08243029 1 Up in IGF1
Dysf 0.536576029 1.198032323 0.032273646 1 Up in IGF1
Ceacam3 0.540113924 0.905068927 0.030406217 1 Up in IGF1
Gabrg3 0.540406371 1.014689649 0.040776547 1 Up in IGF1
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Pspn 0.544208945 0.263200117 0.072343317 1 Up in IGF1
Tnnc2 0.552307259 2.341824551 0.04113891 1 Up in IGF1
Ccdc33 0.555361178 1.64600212 0.077173629 1 Up in IGF1
Ednra 0.556699595 2.041736967 0.069900052 1 Up in IGF1
0.559020746 0.933754891 0.045044335 1 Up in IGF1
Sh3bgr 0.559333188 0.821871644 0.038068715 1 Up in IGF1
Exph5 0.561651296 2.029391302 0.025145468 1 Up in IGF1
Fhod3 0.562819632 3.770273662 0.020771737 1 Up in IGF1
Col6a1 0.564442006 5.895618182 0.064991845 1 Up in IGF1
Meis1 0.564834855 1.468228087 0.06143654 1 Up in IGF1
Gpr88 0.565005743 2.97736489 0.057905145 1 Up in IGF1
Rasgef1c 0.567542456 1.53032321 0.057816687 1 Up in IGF1
Odf3l1 0.568555969 0.471378681 0.11614033 1 Up in IGF1
Tbx18 0.569413158 1.47700926 0.107537773 1 Up in IGF1
Trpc7 0.571883188 1.463657892 0.084676075 1 Up in IGF1
Prss22 0.572231769 0.869213389 0.194743967 1 Up in IGF1
Bend7 0.572712821 0.060011544 0.076372374 1 Up in IGF1
Srms 0.576482119 0.240203815 0.102710812 1 Up in IGF1
Arhgap18 0.576989017 2.845648919 0.037468835 1 Up in IGF1
Lpin3 0.579490772 3.757202176 0.054639072 1 Up in IGF1
Olr951 0.581542868 2.341219579 0.041694467 1 Up in IGF1
Dnase1l2 0.58164211 1.31424808 0.034001048 1 Up in IGF1
Bves 0.584296241 1.49981091 0.060617247 1 Up in IGF1
Ccdc150 0.584540103 0.017636734 0.072155718 1 Up in IGF1
LOC100360835 0.591093657 0.158646414 0.047084625 1 Up in IGF1
Baiap3 0.593999849 2.924132241 0.146074614 1 Up in IGF1
Rxfp3 0.596222165 1.015352475 0.037631514 1 Up in IGF1
Igf1 0.596687354 1.671675382 0.028460293 1 Up in IGF1
Kcnj16 0.596991071 3.710742114 0.038342359 1 Up in IGF1
Sertad3 0.601110635 0.812453453 0.018407795 1 Up in IGF1
Dpp10 0.601764512 4.010507056 0.003980537 0.702797459 Up in IGF1
Cpne7 0.602345844 7.605625771 0.054497569 1 Up in IGF1
Igfbp6 0.603565868 2.355389946 0.058803951 1 Up in IGF1
Pcolce 0.606622421 0.664139863 0.094483477 1 Up in IGF1
RGD1560034 0.612510599 0.248306549 0.03804199 1 Up in IGF1
Avil 0.61939762 1.92297136 0.043909598 1 Up in IGF1
Klhdc8a 0.619994476 1.947888609 0.072554979 1 Up in IGF1
Hcrt 0.623099529 1.131257734 0.010340342 0.909192252 Up in IGF1
Igsf1 0.624620696 5.768781819 0.006855394 0.810426825 Up in IGF1
Gpat2 0.628326699 -0.0659915 0.094200445 1 Up in IGF1
RGD1561149 0.633479636 2.570684806 0.049133499 1 Up in IGF1
0.634771968 1.695962499 0.025178686 1 Up in IGF1
Igkc 0.637492451 7.203284062 0.360383631 1 Up in IGF1
Tpd52l1 0.640373189 3.906079272 0.021200065 1 Up in IGF1
Aplnr 0.644937702 1.161506246 0.039982498 1 Up in IGF1
0.651946613 2.614323453 0.021993828 1 Up in IGF1
Glt8d2 0.653939403 0.823845647 0.013808048 0.944967997 Up in IGF1
Adra2a 0.656304237 2.878980305 0.079003568 1 Up in IGF1
Fxyd6 0.660775368 2.491020658 0.022356098 1 Up in IGF1
Gng4 0.664563099 0.345040298 0.031374516 1 Up in IGF1
Efcab6 0.664791109 3.501350927 0.028510026 1 Up in IGF1
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Chad 0.665207444 0.721992495 0.020040354 1 Up in IGF1
RT1-M1-2 0.673667751 2.308004624 0.021168791 1 Up in IGF1
Mir186 0.675605551 1.236760674 0.003099804 0.619732876 Up in IGF1
Tmie 0.675780689 2.948934567 0.007258352 0.850666296 Up in IGF1
Slc7a3 0.679894245 1.422460321 0.050188449 1 Up in IGF1
Gabra6 0.679965213 2.564311167 0.082985055 1 Up in IGF1
Abi3bp 0.682501834 0.778079286 0.079511305 1 Up in IGF1
Atp6ap1l 0.684591711 1.039506462 0.108701253 1 Up in IGF1
RGD1562726 0.688151479 2.006304017 0.054381386 1 Up in IGF1
Kcnk9 0.689514914 3.485841633 0.039832796 1 Up in IGF1
Cplx3 0.693455286 0.600443572 0.116912211 1 Up in IGF1
Camk2d 0.695530345 5.683447008 0.002266416 0.540559985 Up in IGF1
Magel2 0.695849037 1.966803212 0.084016623 1 Up in IGF1
Ecel1 0.704186932 0.71180937 0.173047863 1 Up in IGF1
Npy2r 0.704643176 2.944290823 0.040536583 1 Up in IGF1
Susd2 0.722301303 4.691010298 0.012447433 0.944967997 Up in IGF1
0.722997189 5.531492902 0.345915413 1 Up in IGF1
Gpr101 0.728637868 0.820334106 0.139862325 1 Up in IGF1
Fam179a 0.729563513 1.421099479 0.150723668 1 Up in IGF1
Dcn 0.733961982 3.658363714 0.010537023 0.909192252 Up in IGF1
0.737790855 1.610530337 0.007931522 0.852687314 Up in IGF1
Plekhg4 0.741694764 0.43405304 0.02323636 1 Up in IGF1
Osr1 0.743756167 0.415502984 0.05667885 1 Up in IGF1
Pnldc1 0.758001818 0.253204221 0.018316807 1 Up in IGF1
Sstr1 0.758701597 3.613394785 0.033385692 1 Up in IGF1
Nppa 0.758855321 3.222644521 0.02277798 1 Up in IGF1
Cntnap3 0.788045557 1.636444973 0.045234852 1 Up in IGF1
Eppin 0.791524462 0.700663619 0.007700348 0.852687314 Up in IGF1
Slc38a4 0.795113378 0.790364492 0.106778843 1 Up in IGF1
AABR07009357.1 0.804199795 0.563807887 0.059482014 1 Up in IGF1
Klhl14 0.809559257 2.300729753 0.022737129 1 Up in IGF1
Sypl2 0.82338483 1.688608836 0.002393796 0.551587466 Up in IGF1
Rpl10l 0.830381891 1.467258079 0.006780029 0.810426825 Up in IGF1
Rps4y2 0.847002651 1.363984194 0.008170274 0.854422119 Up in IGF1
Bace2 0.862946555 1.576478739 0.003842872 0.696584551 Up in IGF1
Stra6 0.864899934 2.200608676 0.001392929 0.452763642 Up in IGF1
Atp2b4 0.901205513 5.03292495 0.011624875 0.944967997 Up in IGF1
Gli1 0.904381531 2.178516407 0.025875365 1 Up in IGF1
Arhgap6 0.912599166 3.291369476 0.002314028 0.54240022 Up in IGF1
Nr2f2 0.919140676 3.874062551 0.00637719 0.810426825 Up in IGF1
Cpne2 0.920595536 3.829272586 0.017022 1 Up in IGF1
Pcdh11x 0.92932649 0.6456199 0.014046043 0.944967997 Up in IGF1
Col6a2 0.945652123 4.553955368 0.019137021 1 Up in IGF1
Ush1g 0.961313946 -0.012397496 0.013181043 0.944967997 Up in IGF1
Nnat 0.979102067 8.186459949 0.005258732 0.741060084 Up in IGF1
Tacr3 0.985738265 1.674987592 0.063571538 1 Up in IGF1
Tpbg 1.014052169 2.745578495 0.02409323 1 Up in IGF1
1.015668417 2.611587192 0.004930062 0.741060084 Up in IGF1
Rxrg 1.031133107 2.697068312 0.026453724 1 Up in IGF1
Tac1 1.035848363 2.016402508 0.006651954 0.810426825 Up in IGF1
Itga8 1.037108992 3.383053124 0.013941849 0.944967997 Up in IGF1
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edgeR Analysis Result
Mx1 1.044799726 2.240562138 0.02124564 1 Up in IGF1
Tcerg1l 1.05362326 2.455553058 0.019142952 1 Up in IGF1
1.096129457 1.532675268 0.00612712 0.793430781 Up in IGF1
Kcnf1 1.098109486 2.613163035 0.03788608 1 Up in IGF1
RGD1311744 1.106999345 2.207978455 0.027107842 1 Up in IGF1
Htr2c 1.125706548 5.438136984 0.014052105 0.944967997 Up in IGF1
Trhr 1.131738805 1.541432031 0.009235951 0.894984764 Up in IGF1
Cdhr1 1.184990172 1.790412841 0.026143422 1 Up in IGF1
Olr59 1.289216772 0.672503751 0.000861696 0.344551554 Up in IGF1
Slc6a5 1.290180474 1.066525458 0.00435839 0.71388326 Up in IGF1
Lum 1.41001991 2.143715398 0.00160026 0.473768859 Up in IGF1
Igj 1.427644154 3.527686377 0.005681698 0.757281205 Up in IGF1
Igh-1a 1.638593475 6.635969662 0.011989283 0.944967997 Up in IGF1
Plagl1 1.656532652 1.954949774 0.00776037 0.852687314 Up in IGF1
Ighm 2.139870407 4.933950804 0.004275374 0.71388326 Up in IGF1
AABR07072761.1 2.636817615 2.985622637 0.000560966 0.262977194 Up in IGF1
LOC365791 3.140251872 2.102807849 8.56317E-06 0.011641627 Up in IGF1
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RESPONSES TO REVIEWERS 
Reviewer: 1 
 
1) Grammar and sentence structure need to be reviewed, some conjunction in 
sentences are missing.  
a. Line 14 of the abstract and 12 of the introduction “…underlie the hippocampal 
phenotype of aging…”  
We have corrected the sentence in the Abstract and Introduction as the reviewer 
recommends. Page 2 line 6 from top and page 4 lines 3-4 from top.  
 
2) Use of the term deregulated on lines 32 and 5 is a bit unclear, use different 
terminology i.e. differentially expressed.  
We have replaced the term “deregulation” by “differentially expressed” in the revised 
version of the manuscript. 
 
3) Add a brief sentence at the end of Escape box latency and exploration frequency 
indicating what a positive outcome is i.e. “short escape box latency time indicates 
better learning…” 
As recommended, we added a short sentence at the end of Escape box latency and 
Exploration frequency, explaining how to interpret the values they take. Page 6 lines 
7_8 and 13_14 from top. 
 
4) Method section mentions that RNA was extracted from 4 rats per group on line 
28, please indicate what the groups are at this point in the manuscript for clarity.  
Also indicate the age of the animals at time of sacrifice and RNA isolation.  
As recommended, we have now indicated what the groups are. As indicated in the 
revised manuscript, rats were sacrificed 80 days post adenovector injection (28 months 
of age). Page 8 line 1 from top and page 8 line 6 from bottom. 
 
 
5) Analysis of variance between the 4 samples in each group should be provided as 
a control. 
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Following the reviewer’s suggestion, homoscedasticity between samples along all genes 
was estimated. Results demonstrate the equality of variances for the 4 samples in each 
group. 
 
 
 
Groups Count Sum Average Variance   
DsRed_7 13595 1008745.059 74.19971013 227038.8892   
DsRed_12 13595 988382.3669 72.70190268 178083.9198   
DsRed_22 13595 990273.8746 72.84103528 190786.6145   
DsRed_25 13595 970285.5989 71.37076859 162182.0955   
       
       
ANOVA       
Source of Variation SS df MS F P-value F crit 
Between Groups 54533.94544 3 18177.98181 0.095914445 0.962316553 2.605072539 
Within Groups 10305496109 54376 189522.8798    
       
Total 10305550643 54379         
 
 
 
Groups Count Sum Average Variance   
IGF.I_16 13595 1001123.491 73.63909457 316598.6918   
IGF.I_24 13595 1037597.863 76.3220201 310851.7393   
IGF.I_27 13595 989975.5446 72.81909118 217186.4508   
IGF.I_29 13595 1015073.515 74.66520889 246754.6292   
       
       
ANOVA       
Source of 
Variation SS df MS F P-value F crit 
Between Groups 92945.92414 3 30981.97471 0.11355036 0.952209853 2.605072539 
Within Groups 14836376201 54376 272847.8778    
       
Total 14836469147 54379         
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6) Have you preformed a stepwise linear regression to see if the addition of IGF-1 
virus can predict the outcome of the rat memory tests? Use the presence or 
absence of IGF as a dependent variable. 
 
In the first part of the question, the reviewer suggests performing a stepwise linear 
regression using the outcome of the memory test as dependent variable, whereas in the 
second part of the question the reviewer suggests using IGF-I addition as dependent 
variable. 
Thus, with the Statistica 8 Software (Tulsa, USA) we have performed both approaches 
for the PT3, the time point at which the IGF-I rats displayed an increase in memory 
accuracy. We have set the variable “goal hole exploration” as memory outcome, 
whereas for “IGF-I addition” we have set the value equal to 1 for IGF-I subjects and 
equal to 0 for DsRed subjects. 
When setting IGF-I addition as independent variable and goal hole exploration as 
dependent variable, we obtained a curve with a R
2
=0.25, as shown below in the 
regression summary document. 
 
Regression Summary for Dependent Variable: Goal Hole exploration (Spreadsheet1)
R= ,50895856 R²= ,25903881 Adjusted R²= ,22199075
F(1,20)=6,9920 p<,01556 Std.Error of estimate: 2,4142
N=22
Beta Std.Err.
of Beta
B Std.Err.
of B
t(20) p-level
Intercept
IGF-I addition
5,100000 0,763435 6,680331 0,000002
0,508959 0,192479 2,733333 1,033696 2,644233 0,015560
When setting IGF-I addition as dependent variable and goal hole exploration as 
independent variable, we obtained a curve with a R
2
=0.25, as shown below in the 
regression summary document. 
 
Regression Summary for Dependent Variable: IGF-I addition (Spreadsheet1)
R= ,50895856 R²= ,25903881 Adjusted R²= ,22199075
F(1,20)=6,9920 p<,01556 Std.Error of estimate: ,44953
N=22
Beta Std.Err.
of Beta
B Std.Err.
of B
t(20) p-level
Intercept
Goal Hole exploration
-0,079168 0,254923 -0,310556 0,759351
0,508959 0,192479 0,094770 0,035840 2,644233 0,015560
 
Thus, we think that the stepwise linear regression does not fit to our data. 
Page 41 of 45
http://mc.manuscriptcentral.com/jgbs
Manuscripts submitted to Journal of Gerontology: Biological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 4
Overall, we believe the stepwise linear regression is not an appropriate statistical 
method to show our results. We would rather use an unpaired t test to compare mean 
goal hole exploration between DsRed and IGF-I groups. We have already used unpaired 
t test to compare goal hole exploration in a previous study [Pardo et al., 2017].  
 
Reference 
Pardo J, Abba MC, Lacunza E, Francelle L, Morel GR, Outeiro TF, Goya RG. 
Identification of a conserved gene signature associated with an exacerbated 
inflammatory environment in the hippocampus of aging rats. Hippocampus. 2017 Jan  
13. doi: 10.1002/hipo.22703. [Epub ahead of print] PubMed PMID: 28085212. 
 
7) The fold change cut off is 0.5? Do you mean to report the log2 fold change from 
DESeq2? Does not seem stringent enough for your cut off. Also, fold change is not 
the DESeq output format. Please indicate how the cut off values were calculated. 
 
We apologize for the mistake introduced in Materials & Methods section regarding the 
method employed in RNAseq data analysis. The Bioconductor package used for the 
differential expression analysis was edge R instead of DESeq2.  
The FC output format corresponds to an analysis of edgeR. In addition, the significance 
level to get the DEG was established at Log2 FC (instead of FC) > 0.5 and p value 
<0.05.  
The corresponding corrections were introduced in the manuscript. Page 9 lines 4_7 from 
bottom and page 22 lines 3-5 from top. 
 
8) A subset of genes should be validated for changes in gene expression by rt-PCR 
or other direct measure of mRNA abundance. 
Following reviewer suggestion, we have validated a subset of the more relevant genes 
by qRT-PCR. Materials and methods and results have been included in the revised 
manuscript and in figure 3D. Page 10 lines 3-8 from top, page 11 line 1 from bottom, 
page 12 lines 1-2 from top, page 28 lines 1-3 from bottom. Primers are listed in Suppl. 
Table 1.  
 
9) Add suggesting statement at the end of Hole exploration frequency results 
section, what do these results indicate? 
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As recommended, at the end of Hole exploration frequency in the Results section, we 
have added a brief interpretation of the data obtained. Page 11 lines 10-12 from top. 
 
10) More detail in results section is required for general audience understanding 
and clarity. 
We have added short interpretative paragraphs at the end of each subsection in Results. 
We believe that the new text will serve better to improve the understandability and 
clarity or our results that would including further technical details. Page 11 lines 5-7 
from bottom and page 13 lines 7-9 from top. 
 
11) More explanation and references needed to explain how you got lists of genes 
used to pull out functional groups of genes is needed. 
We performed a search of the literature in order to identify the differentialy expressed 
genes that were functionally significant concerning, IGF-I itself, neurogenesis, memory 
and synaptic plasticity. In the Discussion we provided a not too extensive review of the 
known role of each of the differentially expressed genes that we selected. Each 
statement was accompanied by relevant references.   
 
12) Reduce the amount of data presented in all lists and tables at the end of the 
manuscript to only those that meet the statistical thresholds or are meaningful to 
the results section of the manuscript. Full lists of data can be supplementary or 
posted on a public domain. It is not useful or helpful to provide a list of 20K genes 
with no annotation or legend. 
As suggested by the reviewer, the now supplementary table 2 was modified and now 
contains the requested information. 
 
13) Label each list/table of RNA seq and DSRed Data and provide legend with 
description. 
Table 1 in the manuscript carries a title and a footnote (legend). The label of the Suppl. 
Table 2 is “List of DEG between IGF1 and DsRED rats (LogFC>1.5; 
pvalue<0.05)”. It is embedded within the Table on the headings grid. 
 
14) The data sets must be deposited in a public database for distribution. 
We are now in the process of depositing RNA seq data in GEO database.  
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Reviewer: 2 
1.  Abstract, Results and Discussion:  The authors should consider using a term 
other than deregulated to describe gene expression changes induced by IGF-1.  
Deregulation is sometimes used to describe dysregulation or lack of regulation.  In 
this study, it doesn’t appear that IGF-1 is causing dysfunctional gene expression 
but rather appears to simply alter the expression of some genes.  This change in 
gene expression may actually be beneficial to the animal.   
As indicated to reviewer 1, we have now replaced the term deregulation by differential 
expression.  
 
2.  Materials and Methods (p. 4):  Information about the diet supplied to the mice 
should be given in the Materials and Methods section.  Diet may influence gene 
transcription, and it would be helpful to have diet information available when 
comparing the results of different studies. 
The diet composition (%) of the animals is now provided in M&M. Page 4 lines 4-7 
from bottom. 
 
3.  Materials and Methods (p. 7) and Figure 1:  Were animals euthanized on day 80 
or 78?  The Methods section indicates that the rats were euthanized on day 80 
while Figure 1 indicates the animals were euthanized on day 78. 
We apologize for this error. Animals were euthanized on day 80. This has now been 
corrected (Fig 1A). 
 
 4.  Discussion (p. 14):  It would be helpful if the authors provided more 
information about the expected outcome of downregulation of Igfbp4 and 
upregulation of Igfbp6.  Is there sufficient information in the literature to allow 
speculation about the net impact of these binding proteins changing in opposite 
directions?   
We believe that there is not enough information in the literature to allow speculation 
about the net impact of these binding proteins changing in opposite directions. Please, 
consider that this is, to our knowledge, the first report on the effects of IGF-I gene 
therapy on the hippocampal transcriptome. As already indicated in the Discussion, our 
data are insufficient to allow a prediction of the net effect of these opposite changes on 
the net hippocampal IGF-I tissue levels in our old rats.  
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5.  Discussion:  Do the authors have a theory as to why a significant difference in 
hole exploration frequency was only observed 77 days (PT3) after IGF-1 gene 
therapy?  
In a previous short-term IGF-I therapy study [Pardo et al., 2016] performed on 28 
months old female rats, we observed an increase in goal hole exploration frequency 
comparable to that induced by the treatment in the present study when the rats reached 
28 months of age. In the present study, the old rats did not show any improvement in 
goal hole exploration frequency at earlier ages (26 and 27 months). Therefore, we 
speculate that 28 months of age might constitute a time window where the sensitivity of 
the animals to IGF-I increases concerning goal hole exploration frequency. This is just a 
possibility that would need experimental confirmation. Since there is no experimental 
support for this hypothesis we prefer not to include it in the MS.   
 
Reference 
Pardo J, Uriarte M, Console GM et al. Insulin-like growth factor-I gene therapy 
increases hippocampal neurogenesis, astrocyte branching and improves spatial memory 
in aging rats; European Journal of Neuroscience. 2016. 44(4):2120-2128. 
Page 45 of 45
http://mc.manuscriptcentral.com/jgbs
Manuscripts submitted to Journal of Gerontology: Biological Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
